Abstract
Electrochemiluminescence (ECL) has a proven track record for the detection of illicit substances, yet little investigation into its application within medical devices has been witnessed to date. The ability to not only detect therapeutic products such as cancer therapies, but monitor these alongside disease biomarkers will provide the prognostic and diagnostic information required by physicians to begin to construct personalised treatment plans. Here we present an initial feasibility study toward the development of a remote ECL sensor for the monitoring of cancer therapy uptake alongside disease biomarkers to facilitate remote and real-time patient monitoring.
Original language | English |
---|---|
Pages | 1 |
DOIs | |
Publication status | Published - 2 Mar 2021 |
Event | 2021 #RSCPoster Twitter Conference - Virtual Duration: 2 Mar 2021 → 3 Mar 2021 https://www.rsc.org/our-events/rsc-poster/ |
Conference
Conference | 2021 #RSCPoster Twitter Conference |
---|---|
Period | 2/03/21 → 3/03/21 |
Internet address |
Keywords
- electrochemiluminescence (ECL)
- biomedical analysis
- cancer research